Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of share options

17 Oct 2017 09:10

RNS Number : 7995T
Touchstone Innovations PLC
17 October 2017
 

17 October 2017

 

Touchstone Innovations plc

 

Grant of share options

 

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation. 

 

Touchstone Innovations plc (AIM: IVO, "Innovations" or "the Group") has today granted options over ordinary shares in the capital of the Group ("Award Shares") to the following PDMRs under its 2016 Long Term Incentive Plan ("LTIP").

 

Number of Award Shares

Russ Cummings

315,515

Nigel Pitchford

94,827

Tony Hickson

55,173

Anjum Ahmad

46,433

 

The options have an exercise price of 3 1/33 (three and one thirty-third) pence per Award Share and are exercisable in three equal tranches during the six month periods commencing on 1 December 2020, 1 December 2021 and 1 December 2022 respectively, subject to certain performance conditions having been satisfied.

 

This grant of options is part of the Company's long-term incentive arrangements designed to align the interests of the shareholders and executives.

 

The LTIP was approved by shareholders of the Company at an annual general meeting on 21 November 2016 and was adopted by the Board on the same day. The LTIP provides for options to acquire ordinary shares to be granted to eligible employees. The arrangements are described more fully in the Directors' Remuneration Report in the Group's 2016 Annual Report, a copy of which is available on the Group's website (www.touchstoneinnovations.com).

 

For further information please contact:

 

Touchstone Innovations plc

020 3053 8834

David Newlands, Chairman

William Rayner, Company Secretary

 

Instinctif Partners

020 7457 2020

Adrian Duffield/Melanie Toyne-Sewell/Chantal Woolcock

 

J.P. Morgan Cazenove (Nominated Adviser)

020 7742 4000

Michael Wentworth-Stanley/Alec Pratt

 

RBC Capital Markets

020 7653 4000

Darrell Uden/Marcus Jackson/Laura White

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Russ Cummings

 

2.

Reason for the notification

a)

Position / status

CHIEF EXECUTIVE OFFICER

b)

Initial notification/amendment

INITIAL NOTIFICATION

3.

Details of issuer

a)

Name

touchstone Innovations plc

b)

LEI

213800D4RUIF3HLITE31

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

NOMINAL VALUE OPTIONS OVER ORDINARY SHARES OF 3 1/33 PENCE EACH IN THE CAPITAL OF THE COMPANY

GB00B170L953

b)

Nature of the transaction

grant of long term incentive plan awards

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

315,515

d)

Aggregated information

 

Aggregated volume price

N/A

 

e)

Date of the transaction

 

2017-10-17

f)

Place of the transaction

OUTSIDE A TRADING VENUE

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

nigel pitchford

2.

Reason for the notification

a)

Position / status

CHIEF INVESTMENT OFFICER

b)

Initial notification/amendment

INITIAL NOTIFICATION

3.

Details of issuer

a)

Name

touchstone Innovations plc

b)

LEI

213800D4RUIF3HLITE31

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

NOMINAL VALUE OPTIONS OVER ORDINARY SHARES OF 3 1/33 PENCE EACH IN THE CAPITAL OF THE COMPANY

GB00B170L953

b)

Nature of the transaction

grant of long term incentive plan awards

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

94,827

d)

Aggregated information

 

Aggregated volume price

N/A

 

e)

Date of the transaction

 

2017-10-17

f)

Place of the transaction

OUTSIDE A TRADING VENUE

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

TONY HICKSON

 

2.

Reason for the notification

a)

Position / status

MANAGING DIRECTOR - TECHNOLOGY TRANSFER

b)

Initial notification/amendment

INITIAL NOTIFICATION

3.

Details of issuer

a)

Name

touchstone Innovations plc

b)

LEI

213800D4RUIF3HLITE31

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

NOMINAL VALUE OPTIONS OVER ORDINARY SHARES OF 3 1/33 PENCE EACH IN THE CAPITAL OF THE COMPANY

GB00B170L953

b)

Nature of the transaction

grant of long term incentive plan awards

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

55,173

d)

Aggregated information

 

Aggregated volume price

N/A

 

e)

Date of the transaction

 

2017-10-17

f)

Place of the transaction

OUTSIDE A TRADING VENUE

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

ANJUM AHMAD

 

2.

Reason for the notification

a)

Position / status

TREASURY AND FINANCE DIRECTOR

b)

Initial notification/amendment

INITIAL NOTIFICATION

3.

Details of issuer

a)

Name

touchstone Innovations plc

b)

LEI

213800D4RUIF3HLITE31

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

NOMINAL VALUE OPTIONS OVER ORDINARY SHARES OF 3 1/33 PENCE EACH IN THE CAPITAL OF THE COMPANY

GB00B170L953

b)

Nature of the transaction

grant of long term incentive plan awards

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

46,433

d)

Aggregated information

 

Aggregated volume price

N/A

 

e)

Date of the transaction

 

2017-10-17

f)

Place of the transaction

OUTSIDE A TRADING VENUE

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEAPEXFENXFEF
Date   Source Headline
28th Jul 20157:01 amRNS£1 million seed investment in Inflowmatix
27th Jul 20157:00 amRNS£3.0 million investment in Concirrus
23rd Jul 20151:35 pmRNSDirectorate Change
14th Jul 20157:00 amRNSFurther £50m loan facility from EIB
2nd Jul 20157:00 amRNS£4.0m funding round in Impression Technologies
1st Jul 20157:00 amRNSFirst subject enrolled in Veryan Medical's study
30th Jun 20157:00 amRNSLeads £3 million investment in Abingdon Health
8th Jun 20151:18 pmRNSDirectorate Change
3rd Jun 20157:00 amRNSInnovations leads £6m funding round in Auspherix
29th May 20157:00 amRNSAppointment of Executive Chairman at Kesios
27th May 20154:05 pmRNSHolding(s) in Company
26th May 20157:01 amRNSDivests its shares of Epigeum
19th May 20157:00 amRNS£25m Series C funding round in PsiOxus
14th May 20157:00 amRNSTopiVert starts Phase I Clinical Trial
30th Apr 20153:48 pmRNSDirector's share purchase
27th Apr 20157:00 amRNSAutifony Therapeutics recruits first trial patient
15th Apr 20157:00 amRNSInnovations leads £5.9m funding round in Yoyo
27th Mar 20157:00 amRNSHalf Yearly Report
24th Mar 20154:40 pmRNSSecond Price Monitoring Extn
24th Mar 20154:35 pmRNSPrice Monitoring Extension
18th Mar 20157:00 amRNSCell Medica granted Orphan Drug designation
13th Mar 201510:07 amRNSEdison publishes research on Imperial Innovations
27th Feb 201511:48 amRNSNotice of Results
19th Feb 20157:00 amRNSCell Medica to commence cell therapy manufacture
14th Jan 201512:13 pmRNS£18 million Series B funding round in Veryan
18th Dec 20147:00 amRNSImperial named UK's top research university
16th Dec 201411:39 amRNSResult of AGM
9th Dec 20142:55 pmRNSGrant of options under SAYE Scheme
26th Nov 20143:41 pmRNSGrant of share options
25th Nov 201410:45 amRNSReplacement Director's share purchase
25th Nov 20147:00 amRNS£50 million Series B funding round in Cell Medica
24th Nov 20144:20 pmRNSDirector's share sale
12th Nov 20147:00 amRNSPosting of Annual Report and Notice of AGM
24th Oct 20147:00 amRNSDirectorate Changes
15th Oct 20147:00 amRNSFinal Results
8th Oct 20147:00 amRNSInnovations invests £1.85m in Kesios Therapeutics
5th Sep 20141:55 pmRNSNotice of Results
13th Aug 201412:43 pmRNSDirector's share sale
15th Jul 20142:08 pmRNSDirectorate Change
7th Jul 20147:14 amRNSPortfolio company Abzena announces offer price
4th Jul 20143:36 pmRNSHolding(s) in Company
23rd Jun 20143:15 pmRNSResults of Placing
23rd Jun 20147:00 amRNSPlacing to raise £150 million
19th Jun 201412:45 pmRNSResult of General Meeting
16th Jun 20147:09 amRNSPortfolio company announces intention to float
12th Jun 20147:00 amRNSImperial Innovations invests £1.5m in Cortexica
10th Jun 20147:00 amRNS£3 million funding round for Featurespace
4th Jun 20147:00 amRNSAutifony receives funding for Phase II trial
2nd Jun 20147:00 amRNSAppointment of non-executive directors
2nd Jun 20147:00 amRNSProposed Placing to raise up to £150 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.